ArticleMaterials today. Bio2026
Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease that severely impairs the quality of life of patients owing to its complex immunopathological mechanisms and persistent joint damage. In recent years, the application of biomaterials in regulating immune responses in RA has attracted extensive attention, particularly regarding the regulatory effects of their physicochemical properties, including surface chemistry, mechanical properties, and morphology, on immune cell behavior and the inflammatory microenvironment. Current studies have revealed that rationally designed biomaterials can modulate inflammatory responses by influencing the activation, differentiation, and signaling pathways of immune cells, thereby providing novel insights into RA treatment. However, the specific regulatory mechanisms underlying different physicochemical properties remain incompletely elucidated, and related research still faces challenges related to material biocompatibility and immune specificity. This article systematically reviews the latest advances in the research of biomaterial physicochemical properties in the field of RA immunomodulation, analyzes the mechanisms of their action in regulating the immune microenvironment, and discusses the potential and future directions of biomaterial-based immunomodulatory strategies in clinical applications to provide theoretical basis and technical support for the development of precision immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.